Navigation Links
ThromboGenics Announces Business Update and 2008 Full Year Results
Date:3/12/2009

s compares to EUR 40.1 million in cash and EUR 6.7 million in short term investments at December 31, 2007. This level of cash resources is expected to allow ThromboGenics to drive forward its operational plans for the next two years.

Patrik De Haes, CEO of ThromboGenics, commenting on today's announcement, said: "ThromboGenics had a very successful 2008, making excellent progress with its development pipeline and reporting a pre-tax profit for the period. The recent start of our Phase III program with microplasmin in patients with back of the eye disease is a major milestone for the Company. Our decision to initiate this pivotal clinical program was driven by the excellent clinical Phase II data that we have generated, combined with our strong financial position. This is the result of the EUR30m upfront payment we received as part of our major strategic licensing deal for TB-403 with Roche, signed in June 2008. We are also making good progress with TB-402, a novel long acting anti-coagulant which we believe has advantages over currently marketed products. As ThromboGenics continues to transform itself into a late-stage development company, I am confident that we have all the tools needed to ensure our corporate success."

For the full report of these results please go to http://www.thrombogenics.com

About ThromboGenics

ThromboGenics is a biotechnology company focused on the discovery and development of biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company's lead product Microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
2. ThromboGenics N.V.: Business Update
3. ThromboGenics Announces Half Year Results 2008
4. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
5. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
6. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
7. ThromboGenics N.V. - Business Update
8. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
9. ThromboGenics Announces 2007 Full Year Results
10. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
11. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Boston, MA (PRWEB) May 19, 2013 ... providing social media training online, has proudly announced that ... for small business has surpassed 175,000 views on YouTube. ... free social media and SEO tips and training for ... see my students find the YouTube tips helpful for ...
(Date:5/17/2013)... . Photographers know ... can see which branch a bird is sitting on, but ... telephoto lens for high-magnification images requires considerable skill. It is ... proteins, the active biomolecules of cells. , Olga Schubert, a ... and her colleagues have now come up with a search ...
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... 17, 2013 The paradigm of ‘one ... systems that can help predict the adverse and therapeutic ... Stepaniants, Head of Computational Biology at the Genomics Laboratory, ... to ensure high-quality genomics when used as part of ... to complex data sets to identify key clinical targets ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... of 16 percent the past two years, Wisconsin's bioscience sector ... brats, and milk, says Gale Davy, author of a report, ... , ,"Can you think of any other industry that's ... of the Wisconsin Association for Biomedical Research & Education ...
... New Jersey - Bruker AXS Inc. announced ... with annual revenues of $5-6 million, from Princeton Gamma-Tech ... disclosed, and the acquisition is expected to close in the ... 14, 2005, that an agreement had been reached to acquire ...
... Biotechnology , a unit of Fisher Biosciences, has contracted ... distribute GenTel's trademarked PATH brand thin-film nitrocellulose slides and ... new protein arrays for life-science research and drug discovery. ... the profiling of disease biomarkers to improve the safety ...
Cached Biology Technology:Bioscience beats beer 2
(Date:5/16/2013)... creature with ,scissor hand-like, claws in fossil records and ... star. , The 505 million year old fossil ... is a distant ancestor of lobsters and scorpions, was ... role as Edward Scissorhands - a movie about an ... scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... entirety of an individual,s DNA is examined to look ... health problems is a massively useful technology for diagnosing ... problems if used incorrectly, say new recommendations from the ... today (16 May 2013) in the European Journal ... genome and on exome* sequencing and analysis are now ...
(Date:5/16/2013)... don,t ponder our pulses outside of the gym. But doctors ... heart health. , Zhenan Bao, a professor of chemical engineering ... dollar bill and no wider than a postage stamp. The ... wrist, is sensitive enough to help doctors detect stiff arteries ... used to continuously track heart health and provide doctors a ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3
... it comes to their social behavior, people sometimes act ... type of monkey that shares with humans strong tendencies ... Dario Maestripieri, an expert on primate behavior and an ... at the University of Chicago. After humans, rhesus ...
... Reserve Universitys School of Medicine have published in ... a natural product derived from the Amazon rainforest. ... of applications in various joint, skin and gastrointestinal ... publication revealed that Progrado, an extract from a ...
... about the confused feelings that occur when you meet ... fit with his or her gender., A new study ... the brains processing of such sensory information about anothers ... , The study concludes that it does, weighing in ...
Cached Biology News:Humans and monkeys share Machiavellian intelligence 2Humans and monkeys share Machiavellian intelligence 3Natural product discovery by Cleveland medical researchers blocks tissue destruction 2Hearing changes how we perceive gender 2Hearing changes how we perceive gender 3Hearing changes how we perceive gender 4
... FHS-LVF, and the CVD-Diffuse We've combined ... Filters to create the world's first notch ... adjustable bandpass. Each filter features an excellent ... These filters -- with interference coatings ...
... LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Diffuse We've ... Variable Filters to create the world's first ... and adjustable bandpass. Each filter features an ... (99.8%). These filters -- with interference ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Request Info...
Biology Products: